My NCBISign In
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
Shundong Cang, Yuehua Ma, Delong Liu
J Hematol Oncol. 2009; 2: 22. Published online 2009 June 1. doi: 10.1186/1756-8722-2-22
PMCID:
PMC2695818
Abstract Full Text PDF–370K

Is Cited by the Following 14 Articles in this Archive:

Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma
Chris ZY Zhang, George G Chen, Juanita L Merchant, Paul BS Lai
Cell Cycle. 2012 January 15; 11(2): 322–334. Published online 2012 January 15. doi: 10.4161/cc.11.2.18758
PMCID:
PMC3293381
Free in PMC on 2013/01/15
Preclinical studies on histone deacetylase inhibitors as therapeutic reagents for endometrial and ovarian cancers
Brahma N Singh, Hongyuan Zhou, Jinping Li, Tracy Tipton, Bin Wang, Guo Shao, E Nickolas Gilbert, Qiang Li, Shi-Wen Jiang
Future Oncol. Author manuscript; available in PMC 2012 October 1.
Published in final edited form as: Future Oncol. 2011 December; 7(12): 1415–1428. doi: 10.2217/fon.11.124
PMCID:
PMC3273414
Free in PMC on 2012/10/01
Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
Chiranjeevi Sandi, Ricardo Mouro Pinto, Sahar Al-Mahdawi, Vahid Ezzatizadeh, Glenn Barnes, Steve Jones, James R. Rusche, Joel M. Gottesfeld, Mark A. Pook
Neurobiol Dis. 2011 June; 42(3): 496–505. doi: 10.1016/j.nbd.2011.02.016
PMCID:
PMC3107941
Abstract Full Text Supplementary Material
Cancer epigenetics: above and beyond
Mariana Brait, David Sidransky
Toxicol Mech Methods. Author manuscript; available in PMC 2012 March 21.
Published in final edited form as: Toxicol Mech Methods. 2011 May; 21(4): 275–288. doi: 10.3109/15376516.2011.562671
PMCID:
PMC3309610
Abstract Full Text PDF–748K
Cancer cells’ epigenetic composition and predisposition to histone deacetylase inhibitor sensitization
Narasimharao Nalabothula, France Carrier
Epigenomics. Author manuscript; available in PMC 2012 February 1.
Published in final edited form as: Epigenomics. 2011 April 1; 3(2): 145–155.
PMCID:
PMC3129700
Abstract Full Text PDF–1.4M
Ex Vivo Activity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates of Plasmodium falciparum and P. vivax
Jutta Marfurt, Ferryanto Chalfein, Pak Prayoga, Frans Wabiser, Enny Kenangalem, Kim A. Piera, David P. Fairlie, Emiliana Tjitra, Nicholas M. Anstey, Kathy T. Andrews, Ric N. Price
Antimicrob Agents Chemother. 2011 March; 55(3): 961–966. Published online 2010 December 6. doi: 10.1128/AAC.01220-10
PMCID:
PMC3067106
Abstract Full Text PDF–242K
Bromodomain Coactivators in Cancer, Obesity, Type 2 Diabetes, and Inflammation
Gerald V. Denis
Discov Med. Author manuscript; available in PMC 2011 January 24.
Published in final edited form as: Discov Med. 2010 December; 10(55): 489–499.
PMCID:
PMC3025494
Abstract Full Text PDF–349K
Reactivating aberrantly hypermethylated p15 gene in leukemic T cells by a phenylhexyl isothiocyanate mediated inter-active mechanism on DNA and chromatin
Shaohong Jiang, Xudong Ma, Yiqun Huang, Yunlu Xu, Ruiji Zheng, Jen-Wei Chiao
J Hematol Oncol. 2010; 3: 48. Published online 2010 November 29. doi: 10.1186/1756-8722-3-48
PMCID:
PMC3009608
Abstract Full Text PDF–652K
Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights
Xiongpeng Zhu, Yuehua Ma, Delong Liu
J Hematol Oncol. 2010; 3: 17. Published online 2010 April 23. doi: 10.1186/1756-8722-3-17
PMCID:
PMC2880983
Abstract Full Text PDF–788K
Epigenetics and cancer
Rajnee Kanwal, Sanjay Gupta
J Appl Physiol. 2010 August; 109(2): 598–605. Published online 2010 March 4. doi: 10.1152/japplphysiol.00066.2010
PMCID:
PMC2928601
Abstract Full Text
Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand
Pimjai Niparuck, Ladda Sorakhunpipitkul, Vichai Atichartakarn, Suporn Chuncharunee, Artit Ungkanont, Pantep Aungchaisuksiri, Teeraya Puavilai, Saengsuree Jootar
J Hematol Oncol. 2010; 3: 1. Published online 2010 January 5. doi: 10.1186/1756-8722-3-1
PMCID:
PMC2828404
Abstract Full Text PDF–172K
Lung cancer: A modified epigenome
Arnaud Van Den Broeck, Peggy Ozenne, Beatrice Eymin, Sylvie Gazzeri
Cell Adh Migr. 2010 Jan-Mar; 4(1): 107–113.
PMCID:
PMC2852567
Abstract Full Text PDF–190K
Hijacking HES1: Tumors Co-opt the Anti-differentiation Strategies of Quiescent Cells
Liyun Sang, James M. Roberts, Hilary A. Coller
Trends Mol Med. Author manuscript; available in PMC 2010 May 6.
Published in final edited form as: Trends Mol Med. 2010 January; 16(1): 17–26. Published online 2009 December 18. doi: 10.1016/j.molmed.2009.11.001
PMCID:
PMC2864914
Abstract Full Text PDF–560K Supplementary Material
Vorinostat in solid and hematologic malignancies
David Siegel, Mohamad Hussein, Chandra Belani, Francisco Robert, Evanthia Galanis, Victoria M Richon, José Garcia-Vargas, Cesar Sanz-Rodriguez, Syed Rizvi
J Hematol Oncol. 2009; 2: 31. Published online 2009 July 27. doi: 10.1186/1756-8722-2-31
PMCID:
PMC2731787
Abstract Full Text PDF–1.0M
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk